| Biotechnology Industry | Healthcare Sector | Mr. Miron Tokarski Ph.D. CEO | WSE Exchange | PLGNMTC00017 ISIN |
| DE Country | 26 Employees | - Last Dividend | - Last Split | - IPO Date |
Clover Corporation Limited is a distinguished entity in the field of manufacturing, refining, and selling tuna oil and encapsulated products with a global footprint that spans Australia, New Zealand, Asia, Europe, and the Americas. Established in 1988, the company has honed its focus towards the development and supply of high-quality docosahexaenoic acid (DHA) tuna oils primarily for the infant formula and pharmaceutical sectors. Operating from its headquarters in Altona North, Australia, Clover Corporation stands as a pioneering force in the nutrition and wellness sector, leveraging advanced technologies and processes to meet the demanding standards of its international clientele.
This product line represents Clover Corporation's premium offering of docosahexaenoic acid (DHA) tuna oils, meticulously designed for incorporation into infant formula and various pharmaceutical products. The Nu-Mega HiDHA brand encapsulates the company’s commitment to providing vital nutritional components essential for early development and wellbeing.
The Ocean Gold brand covers a range of cold pressed and refined tuna oils, tailored for applications that demand purity and quality. These oils manifest Clover Corporation’s capability to cater to diverse market needs, extending beyond infant nutrition to encompass broader wellness and dietary supplements.
Encompassing a versatile range of DHA powders, the Nu-Mega Driphorm series is engineered for integration into a wide array of food applications. This includes infant formula, follow-on formula, growing up milks, and other food applications, offering a flexible solution to enrich products with the nutritional benefits of DHA.
Specifically formulated for non-dairy applications, the Nu-Mega Driphorm HA signifies Clover Corporation’s innovative approach in expanding the accessibility of DHA enrichment to a variety of dietary preferences and restrictions, ensuring the provision of essential nutrients in a more inclusive manner.
Clover Corporation’s expertise encompasses not only the production of DHA-rich oils and powders but also advanced microencapsulation technology. This technique enables the effective, stable inclusion of sensitive ingredients in a myriad of products, safeguarding the integrity and efficacy of the nutritional compounds throughout the product lifecycle.